Clinical Effects of Guardcel® Nasal Packing on Endonasal Dacryocystorhinostomy

ABSTRACT

Purpose@#To compare the clinical effects of Guardcel® (Genewel. Co, Seongnam, Korea) and Nasopore®(Polyganics, Rozenburglaan, Groningen, The Netherlands), two types of absorbable nasal packing materials after endonasal dacryocystorhinostomy. @*Methods@#A total of 41 patients (49 eyes) who underwent endonasal dacryocystorhinostomy from March 2017 to January 2019 were studied retrospectively. Twenty seven eyes were packed with Guardcel® and twenty two eyes with Nasopore®. We compared the postoperative anatomical and functional surgical success rates between the groups at 1 week, 1 month, 2 months, and 6 months , as well as the frequency of postoperative complications including bleeding. @*Results@#There was no significant difference between the Guardcel® and Nasopore® groups in the postoperative anatomical and functional surgical success rate at 1 week, 1 month, 2 months, or 6 months. Also, there was no significant group difference in the incidence of postoperative complications. @*Conclusions@#The anatomical and functional surgical success rates and incidence of postoperative complications, including bleeding, synechiae, infection, granuloma, and revision were similar between the Guardcel® and Nasopore® groups. Therefore, Guardcel® can be used safely and effectively as an absorbable nasal packing material in endonasal dacryocystorhinostomy treatment.